当前位置:首页 - 行情中心 - 北大医药(000788) - 财务分析 - 利润表

北大医药

(000788)

  

流通市值:36.53亿  总市值:36.53亿
流通股本:5.96亿   总股本:5.96亿

利润表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、营业总收入957,309,406.16502,359,685.422,060,014,642.651,534,330,245.12
  营业收入957,309,406.16502,359,685.422,060,014,642.651,534,330,245.12
二、营业总成本837,453,429.08449,551,963.271,856,768,030.421,371,419,826.74
  营业成本710,055,592.22382,158,273.991,507,540,914.041,108,500,741.03
  税金及附加5,161,517.292,491,717.210,904,583.938,032,811.75
  销售费用66,029,184.537,062,146.95202,183,825.02168,872,186.41
  管理费用45,767,951.6623,406,614.27109,751,555.2573,033,945.27
  研发费用11,833,550.535,179,004.7427,041,662.0213,294,511.08
  财务费用-1,394,367.12-745,793.88-654,509.84-314,368.8
  其中:利息费用1,320,858.961,855,384.784,168,555.12,421,511.97
  其中:利息收入2,791,137.863,831,511.715,025,465.722,880,150.25
三、其他经营收益
  加:投资收益---235,738.82-
  资产处置收益-45,752.14-185,840.72185,840.72
  资产减值损失(新)-51,160.27-5,916.05-46,250,443.11-4,282,872.37
  信用减值损失(新)-1,387,658.8-933,768.6911,529,003.172,203,524.12
  其他收益2,013,249.741,113,371.753,521,782.222,914,977.22
四、营业利润120,384,655.6152,981,409.16171,997,056.41163,931,888.07
  加:营业外收入1,695,301.341,654,364.321,160,586.09176,145.37
  减:营业外支出56,069.9654,741.02804,590.68796,552.43
五、利润总额122,023,886.9954,581,032.46172,353,051.82163,311,481.01
  减:所得税费用21,729,977.838,940,482.2534,360,447.0932,997,749.93
六、净利润100,293,909.1645,640,550.21137,992,604.73130,313,731.08
(一)按经营持续性分类
  持续经营净利润100,293,909.1645,640,550.21137,992,604.73130,313,731.08
(二)按所有权归属分类
  归属于母公司股东的净利润100,293,909.1645,640,550.21137,992,604.73130,364,988.72
  少数股东损益----51,257.64
  扣除非经常损益后的净利润98,163,827.2843,984,087.53127,259,270.95129,545,990.23
七、每股收益
  (一)基本每股收益0.170.080.230.22
  (二)稀释每股收益0.170.080.230.22
九、综合收益总额100,293,909.1645,640,550.21137,992,604.73130,313,731.08
  归属于母公司股东的综合收益总额100,293,909.1645,640,550.21137,992,604.73130,364,988.72
  归属于少数股东的综合收益总额----51,257.64
公告日期2025-08-222025-04-252025-04-252024-10-26
审计意见(境内)标准无保留意见
TOP↑